Efficacy and quality of life (QoL) of cabazitaxel/prednisone (Cbz) in Canadian metastatic castration resistant prostate cancer (mCRPC) patients (pts) with or without prior abiraterone acetate (Abi).
Fred Saad
Consultant or Advisory Role - Sanofi
Honoraria - Sanofi
Research Funding - Sanofi
Eric Winquist
No relevant relationships to disclose
Stacey Hubay
No relevant relationships to disclose
Scott R. Berry
Consultant or Advisory Role - Sanofi
Honoraria - Sanofi
Hazem Assi
No relevant relationships to disclose
Eric Levesque
No relevant relationships to disclose
Nathalie Aucoin
Consultant or Advisory Role - Sanofi
Piotr Czaykowski
Research Funding - Sanofi
Jean-Baptiste Lattouf
Consultant or Advisory Role - Sanofi
Honoraria - Sanofi
Research Funding - Sanofi
Karine Alloul
Employment or Leadership Position - Sanofi
John Stewart
Employment or Leadership Position - Sanofi
Stock Ownership - Sanofi
Srikala S. Sridhar
No relevant relationships to disclose